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Brief Clinical ReportsAllograft sternochondral replacement after resection of large
sternal chondrosarcomaGiuseppe Marulli, MD,a Abdel-Mohsen Hamad, MD,a Elisa Cogliati, MD,b Cristiano Breda, MD,a
Andrea Zuin, MD,a and Federico Rea, MD,a Padova and Treviso, ItalySurgical excision with a safety margin is the cornerstone
of treatment of malignant sternal tumors. After sternal resec-
tion, the primary goals of chest wall reconstruction are to
prevent flail chest with ventilatory impairment, protect the
underlying mediastinal structures, and avoid chest defor-
mity. Various techniques and several materials have been
used over the years for this purpose.1 This report describes
the use of sternal allograft to reconstruct the chest wall after
sternal resection.CLINICAL SUMMARY
A 51-year-old patient presented with an orange-sized,
painless, central anterior chest-wall mass. The mass was
originally discovered 7 months before by the patient as
a small palpable nodule that gradually increased in size.
When the mass became more prominent, the patient sought
medical advice. Ultrasound-guided needle biopsy was per-
formed revealing a diagnosis of chondrosarcoma.
Preoperative computed tomography scan (Figure 1, A)
showed a mass involving the sternal body with destruction
of bony cortex and little extension to presternal soft tissue
and chest wall adjacent to the left border of the sternum.
The patient underwent surgical resection. The pectoralis
majors were dissected bilaterally via an elliptical incision in-
volving the skin and soft tissue overlying the mass. Then,
a full-thickness resection of the sternal body with attached
costal cartilages (from third to seventh) bilaterally was per-
formed.
The defect was reconstructed by using a cryopreserved
allograft sternum with attached costal cartilages. The bone
graft was harvested from a suitable donor under a complete
aseptic technique and treated with antibiotic solution for 72
hours at þ4C and then submitted to cryopreservation at
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available at www.bancatessuti-treviso.org).
On ordering, the graft was thawed and transferred inside
double sterile bags in an ice container (with this protocol
the graft can be stored in refrigerator atþ4C for a maximum
of 1 week). At the time of use, the graft was taken out of ster-
ile bags and washed with saline solution (Figure 1, B).
The graft was tailored to perfectly fit the defect and fixed
with titanium plates and screws (Synthes, Solothurn, Swit-
zerland) at the level of manubrium above and ribs bilaterally
(Figure 1, C). The pectoralis major muscle flaps were ap-
proximated to cover the graft.
The patient was extubated in the operating room. The
postoperative course was uneventful, and the patient was
discharged on the seventh postoperative day. Histologic ex-
amination of the specimen confirmed the diagnosis of chon-
drosarcoma with moderate grade (G2) of differentiation and
negative resection margins.
Nine months after surgery, the patient is alive and doing
well. No signs of rejection, bone necrosis, or infection
were noted during follow-up (Figure 2). Magnetic resonance
imaging demonstrated perfect apposition and healing of the
allograft to the recipient’s tissue.
DISCUSSION
Prosthetic materials are the most commonly used tech-
nique for chest wall reconstruction.1 Although these mate-
rials are widely available and easy to use, they suffer from
excessive rigidity (methylmethacrylate) with erosion of
adjacent structures or insufficient support (Prolene mesh);
moreover, incorporation into the host tissue never occurs.
A search for the ideal material for chest wall reconstruc-
tion continues to challenge thoracic surgeons. Bone grafts
have been proposed as an effective alternative to synthetic
materials. The use of bone autograft (ribs or iliac bone)2,3
or allograft4 has been reported as a valid solution to cover
small chest wall defects. The advantages of autografts are
easy incorporation into the recipient bone, low risk of infec-
tion, and absent risk of rejection.
However, there is a limitation regarding the amount of
bone that can be harvested and transferred to the new site,
in addition to the potential complications at the donor site.
Moreover, harvesting and grafting of vascularized bone are
not easy.
Previous experimental and clinical experiences demon-
strated that the cryopreserved bone graft retains somerdiovascular Surgery c Volume 139, Number 4 e69
FIGURE 2. Postoperative chest x-ray posteroanterior (A) and lateral (B) views showing proper position of the new sternum without signs of necrosis.
FIGURE 1. (A) Preoperative sagittal reconstruction of computed tomography scan showing the extent of the tumor (involving only the body). (B) The sternal
allograft ready to be used before tailoring. (C) Intraoperative view showing the tailored sternal allograft fixed in place.
Brief Clinical Reportsproperties, such as osteoconductive and osteoinductive ca-
pacity. The graft acts as a scaffold for new bone formation,
allowing the ingrowth of capillaries and perivascular tissue
into its structure. Moreover, recruitment of undifferentiated
mesenchymal cells from adjacent tissue with subsequent dif-
ferentiation into osteoprogenitor cells under inductive stim-
ulus of bone growth factors has been proved.5
To our knowledge, this is the first report of sternal replace-
ment with allogenic cryopreserved sternum and costal carti-
lages. It was effective for geometrically covering the entire
large anterior chest wall defect by using the same amount
of bone and cartilages removed in the recipient. The use of
titanium plates and screws easily permitted a perfect fixation
to the bone of the host.e70 The Journal of Thoracic and Cardiovascular SurgCONCLUSIONS
This case demonstrated that sternal allograft is an effective
and biologically well-tolerated option for sternal replacement.References
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